| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87428 |
|
16,223 |
14,579 |
$1.10M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
85,046 |
67,259 |
$857K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,618 |
6,479 |
$569K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,000 |
6,928 |
$567K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14,429 |
13,240 |
$520K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,044 |
5,926 |
$458K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
35,827 |
17,172 |
$378K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,862 |
4,545 |
$353K |
| S8301 |
Infection control supplies, not otherwise specified |
26,084 |
23,357 |
$308K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,281 |
4,844 |
$202K |
| 99429 |
|
5,504 |
5,402 |
$177K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,061 |
8,517 |
$151K |
| 99051 |
|
26,463 |
23,141 |
$128K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,030 |
1,000 |
$80K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,231 |
876 |
$69K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,202 |
4,451 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,025 |
12,523 |
$46K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,974 |
7,410 |
$45K |
| 99000 |
|
19,528 |
18,436 |
$43K |
| 90834 |
Psychotherapy, 45 minutes with patient |
541 |
449 |
$40K |
| 90461 |
|
4,393 |
3,642 |
$30K |
| 99050 |
|
2,578 |
2,212 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,556 |
4,406 |
$29K |
| 0071A |
|
691 |
626 |
$27K |
| 0001A |
|
673 |
642 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
495 |
474 |
$25K |
| 99381 |
|
298 |
290 |
$24K |
| 86580 |
|
2,612 |
2,504 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,480 |
7,144 |
$17K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
220 |
152 |
$17K |
| 96160 |
|
6,492 |
6,403 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,149 |
3,734 |
$13K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,688 |
2,554 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
406 |
396 |
$12K |
| 0002A |
|
266 |
265 |
$11K |
| 87807 |
|
2,230 |
2,050 |
$10K |
| 0072A |
|
176 |
174 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,241 |
2,540 |
$5K |
| 90480 |
|
130 |
128 |
$4K |
| 0003A |
|
84 |
84 |
$3K |
| 81002 |
|
3,307 |
3,101 |
$2K |
| 0081A |
|
78 |
67 |
$2K |
| 90837 |
Psychotherapy, 53 minutes with patient |
17 |
12 |
$2K |
| 94010 |
|
171 |
168 |
$1K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
89 |
88 |
$1K |
| 97169 |
|
142 |
121 |
$1K |
| 86318 |
|
352 |
347 |
$991.40 |
| 0073A |
|
16 |
16 |
$600.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
21 |
17 |
$563.29 |
| 96380 |
|
40 |
38 |
$439.07 |
| 90686 |
|
7,429 |
7,330 |
$332.98 |
| 99242 |
|
24 |
24 |
$269.76 |
| 81025 |
|
122 |
115 |
$173.52 |
| G9716 |
Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason |
9,096 |
8,915 |
$157.96 |
| 92567 |
|
37 |
35 |
$149.88 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
889 |
864 |
$131.38 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
39 |
$75.80 |
| 90651 |
|
2,033 |
1,986 |
$66.18 |
| 96161 |
|
442 |
440 |
$22.50 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
164 |
160 |
$4.87 |
| 85018 |
|
12 |
12 |
$3.99 |
| 90677 |
|
867 |
865 |
$0.49 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
9,104 |
8,928 |
$0.39 |
| 90620 |
|
1,838 |
1,811 |
$0.38 |
| 90734 |
|
2,196 |
2,170 |
$0.01 |
| 90723 |
|
2,578 |
2,544 |
$0.00 |
| 90716 |
|
1,911 |
1,877 |
$0.00 |
| 3008F |
|
9,107 |
8,924 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
15,746 |
15,132 |
$0.00 |
| 90680 |
|
2,353 |
2,319 |
$0.00 |
| 96127 |
|
359 |
348 |
$0.00 |
| 90698 |
|
370 |
363 |
$0.00 |
| 90696 |
|
574 |
558 |
$0.00 |
| 36416 |
|
12 |
12 |
$0.00 |
| 91307 |
|
675 |
611 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
38 |
37 |
$0.00 |
| 90670 |
|
2,627 |
2,580 |
$0.00 |
| 90633 |
|
1,873 |
1,851 |
$0.00 |
| 90648 |
|
2,586 |
2,550 |
$0.00 |
| 90715 |
|
860 |
853 |
$0.00 |
| 90672 |
|
15 |
15 |
$0.00 |
| 90707 |
|
1,879 |
1,851 |
$0.00 |
| 91300 |
|
945 |
865 |
$0.00 |
| 91308 |
|
107 |
87 |
$0.00 |
| 91321 |
|
28 |
27 |
$0.00 |